Efficacy and Tolerability of TENS in Endometriosis-related Pain (NCT07393295) | Clinical Trial Compass
RecruitingNot Applicable
Efficacy and Tolerability of TENS in Endometriosis-related Pain
France92 participantsStarted 2026-03-15
Plain-language summary
ELECTRE is a single-center, randomized, prospective, longitudinal, controlled, two-arm, single-blind study lasting 4 weeks (P1 investigation phase) after a 4-week run-in period.
The study is followed by a 4-week extension phase (P2) in which all participants will be treated with active TENS.
Randomization will be balanced according to a 1:1 ratio.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Women aged ≥ 18 years
✓. Endometriosis and/or adenomyosis diagnosed by imaging and/or histology
✓. Undergoing continuous, stable, and functional hormone treatment (with no menstruation) for at least 2 months
✓. No change in hormone treatment planned for the duration of the study
✓. Chronic pelvic pain for more than 6 months
✓. Pelvic pain at least equal to 2 out of 3 (on the intensity scale: "0 - None," "1 - Mild," "2 - Moderate," "3 - Severe")
✓. Agreeing to participate in the study
✓. Agrees to limit pain relief treatment during the study to level I painkillers paracetamol and Acupan® (nefopam), and the NSAID Antadys® (flurbiprofen)
Exclusion criteria
✕. Pregnant or breastfeeding women
✕. Menopausal women
✕. Patients who, in the investigator's opinion, have experienced an acute worsening of endometriosis symptoms in the last 28 days
✕. Patients with altered sensitivity in the area where the device is applied (hypoesthesia)